Senti Biosciences Inc. (SNTI)
NASDAQ · Healthcare
Senti Biosciences Inc. Shareholder Equity 2021–2025
Senti Biosciences Inc. annual shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Senti Biosciences Inc. shareholder equity as of December 31, 2025: 5.6M, a 78.21% decrease year-over-year.
- Senti Biosciences Inc. shareholder equity for 2025 were 5.6M, a 78.21% decrease from 2024.
- Senti Biosciences Inc. shareholder equity for 2024 were 25.6M, a 61.67% decrease from 2023.
- Senti Biosciences Inc. shareholder equity for 2023 were 66.9M, a 47.42% decrease from 2022.
- Senti Biosciences Inc. shareholder equity for 2022 were 127.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Senti Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $6 |
| 2024 | $26 |
| 2023 | $67 |
| 2022 | $127 |
| 2021 | $-111 |
Senti Biosciences Inc. Shareholder Equity — FAQ
Senti Biosciences Inc. (SNTI) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNTI's shareholder equity history?
The chart and table above show Senti Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.